公开(公告)号：US20210269508A1

公开(公告)日：2021-09-02

申请号：US17320661

申请日：2021-05-14

申请人： Cellastra Inc.

发明人： Bradley G. THOMPSON

IPC分类号： C07K14/79 ,  A61K31/198 ,  A61P17/02 ,  A61K48/00 ,  C12N15/69

摘要： The present disclosure relates to the composition of one or more agents, therapies, treatments, and methods of use of the agents and/or therapies and/or treatments for upregulating production of lactoferrin or a sub-peptide of lactoferrin. Embodiments of the present disclosure can be used as a therapy or a treatment of adhesions or scarring.

公开(公告)号：US11891429B2

公开(公告)日：2024-02-06

申请号：US17320661

申请日：2021-05-14

申请人： Cellastra Inc.

发明人： Bradley G. Thompson

IPC分类号： C12N15/79 ,  C07H21/04 ,  C07K14/79 ,  A61K31/198 ,  A61P17/02 ,  A61K48/00 ,  C12N15/69 ,  A61K38/40 ,  C12N15/86

CPC分类号： C07K14/79 ,  A61K31/198 ,  A61K48/0058 ,  A61K48/0066 ,  A61P17/02 ,  C12N15/69 ,  A61K38/40 ,  C07H21/04 ,  C12N15/86

摘要： The present disclosure relates to the composition of one or more agents, therapies, treatments, and methods of use of the agents and/or therapies and/or treatments for upregulating production of lactoferrin or a sub-peptide of lactoferrin. Embodiments of the present disclosure can be used as a therapy or a treatment of adhesions or scarring.